Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b69b041128b85c38a4e5233a394773f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c7cecac0032a0baad15c729e4c74512 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_988543aa44d954f2adf85198595ec5a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56ff8539f4138c96b25777ecd70c4898 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8c0982b0f02b1ed6d20a315370a3a3a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30141580e12714e703d79f3ea3f571d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4be7a858e7d771a5dde04b23cab6e1f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae7e78ba936231bfbe885543fd866822 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee29107783095e21acac303ab5c5f3c0 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1272 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1271 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6911 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6913 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y5-00 |
filingDate |
2011-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_108b721d3503549e66853a3df940f1ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4b4e7d9e2c7207f4d014038a8b063e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3041017087739d2b1df2ea7fb0ff9d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a1c37eded40ec6c6ebc91767820435e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f15e094eff8bc68bd1ba0eb3aeceb44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdd1caaca092f69592be2c521128dbb0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_569641dc7a1ef0117066980653fb1072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11c800769c2a5709ddf94c60404e0a56 |
publicationDate |
2012-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2012031175-A2 |
titleOfInvention |
Nanoparticle-based tumor-targeted drug delivery |
abstract |
The present invention provides an aqueous tumor-targeting liposome nanoparticle composition comprising an aqueous dispersion of liposome nanoparticles. The nanoparticles preferably encapsulate an anti-cancer chemotherapeutic agent, which can be added to a pre-formed liposome composition or can be incorporated in the liposomes during the formation of the liposomes. The liposome nanoparticles comprise a legumain-targeting lipid admixed with one or more other micelle or vesicle-forming lipid materials in the form of nanoparticulate liposomes dispersed in an aqueous carrier. A preferred tumor-targeting liposome nanoparticle composition comprises (a) a legumain-targeting lipid component, (b) a zwitterionic lipid component; (c) an amino-substituted lipid component; (d) a neutral lipid component; and (e) polyethylene glycol-conjugated lipid component. The legumain-targeting lipid component comprising a hydrophobic lipid portion covalenetly attached to a legumain-binding moiety. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013135359-A1 |
priorityDate |
2010-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |